These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9852059)

  • 1. Evidence for the location of bicyclomycin binding to the Escherichia coli transcription termination factor Rho.
    Riba I; Gaskell SJ; Cho H; Widger WR; Kohn H
    J Biol Chem; 1998 Dec; 273(51):34033-41. PubMed ID: 9852059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibiotic bicyclomycin affects the secondary RNA binding site of Escherichia coli transcription termination factor Rho.
    Magyar A; Zhang X; Kohn H; Widger WR
    J Biol Chem; 1996 Oct; 271(41):25369-74. PubMed ID: 8810302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bicyclomycin and dihydrobicyclomycin inhibition kinetics of Escherichia coli rho-dependent transcription termination factor ATPase activity.
    Park HG; Zhang X; Moon HS; Zwiefka A; Cox K; Gaskell SJ; Widger WR; Kohn H
    Arch Biochem Biophys; 1995 Nov; 323(2):447-54. PubMed ID: 7487110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural mechanism of inhibition of the Rho transcription termination factor by the antibiotic bicyclomycin.
    Skordalakes E; Brogan AP; Park BS; Kohn H; Berger JM
    Structure; 2005 Jan; 13(1):99-109. PubMed ID: 15642265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the bicyclomycin binding domain through biochemical analysis of antibiotic-resistant rho proteins.
    Magyar A; Zhang X; Abdi F; Kohn H; Widger WR
    J Biol Chem; 1999 Mar; 274(11):7316-24. PubMed ID: 10066795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a technique to determine bicyclomycin-rho binding and stoichiometry by isothermal titration calorimetry and mass spectrometry.
    Brogan AP; Widger WR; Bensadek D; Riba-Garcia I; Gaskell SJ; Kohn H
    J Am Chem Soc; 2005 Mar; 127(8):2741-51. PubMed ID: 15725032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription termination factor rho: the site of bicyclomycin inhibition in Escherichia coli.
    Zwiefka A; Kohn H; Widger WR
    Biochemistry; 1993 Apr; 32(14):3564-70. PubMed ID: 8466900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C(5)-C(5a)-modified bicyclomycins: synthesis, structure, and biochemical and biological properties.
    Vincent F; Srinivasan J; Santillán A; Widger WR; Kohn H
    J Org Chem; 2001 Apr; 66(7):2251-64. PubMed ID: 11281764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5a-formylbicyclomycin: studies on the bicyclomycin-Rho interaction.
    Vincent F; Widger WR; Openshaw M; Gaskell SJ; Kohn H
    Biochemistry; 2000 Aug; 39(31):9067-76. PubMed ID: 10924099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis for the mode of action of bicyclomycin.
    Kohn H; Widger W
    Curr Drug Targets Infect Disord; 2005 Sep; 5(3):273-95. PubMed ID: 16181146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bicyclomycin sensitivities of 38 bicyclomycin-resistant mutants of transcription termination protein rho and the location of their mutations support a structural model of rho based on the F(1) ATPase.
    Moyse KA; Knight JS; Richardson JP
    J Mol Biol; 2000 Sep; 302(3):565-79. PubMed ID: 10986119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho transcription factor: symmetry and binding of bicyclomycin.
    Vincent F; Openshaw M; Trautwein M; Gaskell SJ; Kohn H; Widger WR
    Biochemistry; 2000 Aug; 39(31):9077-83. PubMed ID: 10924100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bicyclomycin fluorescent probes: synthesis and biochemical, biophysical, and biological properties.
    Brogan AP; Widger WR; Kohn H
    J Org Chem; 2003 Jul; 68(14):5575-87. PubMed ID: 12839449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8-Azido-ATP inactivation of Escherichia coli transcription termination factor Rho. Modification of one subunit inactivates the hexamer.
    O I; Stitt BL
    J Biol Chem; 1994 Feb; 269(7):5009-15. PubMed ID: 8106476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mg2+ requirements for rho transcription termination factor: catalysis and bicyclomycin inhibition.
    Weber TP; Widger WR; Kohn H
    Biochemistry; 2002 Oct; 41(41):12377-83. PubMed ID: 12369827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bicyclomycin on RNA- and ATP-binding activities of transcription termination factor Rho.
    Carrano L; Bucci C; De Pascalis R; Lavitola A; Manna F; Corti E; Bruni CB; Alifano P
    Antimicrob Agents Chemother; 1998 Mar; 42(3):571-8. PubMed ID: 9517934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Screen for
    Hu K; Artsimovitch I
    mBio; 2017 May; 8(3):. PubMed ID: 28559482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ATP binding site on rho protein. Affinity labeling of Lys181 by pyridoxal 5'-diphospho-5'-adenosine.
    Dombroski AJ; LaDine JR; Cross RL; Platt T
    J Biol Chem; 1988 Dec; 263(35):18810-5. PubMed ID: 3143717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATPase activity of transcription-termination factor rho: functional dimer model.
    Seifried SE; Easton JB; von Hippel PH
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10454-8. PubMed ID: 1438233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escherichia coli transcription termination factor rho has a two-domain structure in its activated form.
    Bear DG; Andrews CL; Singer JD; Morgan WD; Grant RA; von Hippel PH; Platt T
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):1911-5. PubMed ID: 2580303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.